1887
Volume 2022, Issue 3
  • ISSN: 0253-8253
  • EISSN: 2227-0426

Abstract

Healthcare professionals monitoring vaccine-related adverse responses should be aware of COVID-19 vaccine-related acute respiratory distress syndrome to enable expeditious diagnosis and treatment. We report the first case of acute respiratory distress syndrome in a young pregnant woman, occurring immediately after a second dose of the Pfizer-BioNTech BNT16B2b2 mRNA COVID-19 vaccine and requiring a brief period of mechanical ventilation, with a good response to a two-week steroid course. She had recovered from mild COVID-19 infection requiring home isolation nine months prior to the current vaccination dose. Without depreciating the colossal benefit of the COVID-19 vaccine, vaccine-related acute respiratory distress syndrome should be listed as a possible adverse reaction.

Loading

Article metrics loading...

/content/journals/10.5339/qmj.2022.40
2022-08-09
2022-09-29
Loading full text...

Full text loading...

/deliver/fulltext/qmj/2022/3/qmj.2022.40.html?itemId=/content/journals/10.5339/qmj.2022.40&mimeType=html&fmt=ahah

References

  1. Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020 Dec 31; 383:(27):2603–2615. doi: 10.1056/NEJMoa2034577.
    [Google Scholar]
  2. Tarawneh O, Tarawneh H. Immune thrombocytopenia in a 22-year-old post Covid-19 vaccine. Am J Hematol. 2021; 96:(5):E133–E134. doi: 10.1002/ajh.26106.
    [Google Scholar]
  3. Yoshifuji A, Ishioka K, Masuzawa Y, Suda S, Murata S, Uwamino Y, et al. COVID-19 vaccine induced interstitial lung disease. J Infect Chemother. 2022 Jan; 28:(1):95–98. doi:10.1016/j.jiac.2021.09.010.
    [Google Scholar]
  4. DeDent AM, Farrand E. Vaccine-induced interstitial lung disease: A rare reaction to COVID-19 vaccination. Thorax 2022; 77:(1):9–10.
    [Google Scholar]
  5. Pratama NR, Wafa IA, Budi DS, Putra M, Wardhana MP, Wungu CDK. mRNA Covid-19 vaccines in pregnancy: A systematic review. PLoS One. 2022 Feb 2; 17:(2):e0261350. doi: 10.1371/journal.pone.0261350 .
    [Google Scholar]
  6. Leik NKO, Ahmedy F, Guad RM, Baharuddin DMP. Covid-19 vaccine and its consequences in pregnancy: Brief review. Ann Med Surg (Lond). 2021 Dec;72:103103. doi: 10.1016/j.amsu.2021.103103 .
    [Google Scholar]
  7. Serazin NA, Edem B, Williams SR, Ortiz JR, Kawade A, Das MK, et al. Acute respiratory distress syndrome (ARDS) as an adverse event following immunization: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2021 May 21; 39:(22):3028–3036. doi: 10.1016/j.vaccine.2021.01.053.
    [Google Scholar]
  8. Klein NP, Lewis N, Goddard K, Fireman B, Zerbo O, Hanson KE, et al. Surveillance for adverse events after COVID-19 mRNA vaccination. JAMA. 2021 Oct 12; 326:(14):1390–1399. doi: 10.1001/jama.2021.15072.
    [Google Scholar]
  9. Banerji A, Wickner PG, Saff R, Stone CA Jr, Robinson LB, Long AA, et al. mRNA vaccines to prevent COVID-19 disease and reported allergic reactions: Current evidence and suggested approach. J Allergy Clin Immunol Pract. 2021 Apr; 9:(4):1423–1437. doi: 10.1016/j.jaip.2020.12.047.
    [Google Scholar]
  10. Park JY, Kim JH, Lee IJ, Kim HI, Park S, Hwang YI, et al. COVID-19 vaccine-related interstitial lung disease: A case study. Thorax. 2022; 77:(1):102–104. doi: 10.1136/thoraxjnl-2021-217609.
    [Google Scholar]
  11. Munoz FM, Cramer JP, Dekker CL, Dudley MZ, Graham BS, Gurwith M, et al. Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2021; 39:(22):3053–3066. doi: 10.1016/j.vaccine.2021.01.055.
    [Google Scholar]
  12. Camus P, Fanton A, Bonniaud P, Camus C, Foucher P. Interstitial lung disease induced by drugs and radiation. Respiration. 2004 Jul-Aug; 71:(4):301–326. doi: 10.1159/000079633.
    [Google Scholar]
  13. World Health Organization. Causality assessment of an adverse event following immunization (AEFI). In: User manual for the revised WHO classification. Second ed. Geneva, Switzerland: WHO; 2018.
    [Google Scholar]
  14. So C, Izumi S, Ishida A, Hirakawa R, Kusaba Y, Hashimoto M, et al. COVID-19 mRNA vaccine-related interstitial lung disease: Two case reports and literature review. Respirol Case Rep. 2022; 10:(4):e0938. doi: 10.1002/rcr2.938.
    [Google Scholar]
  15. Kono A, Yoshioka R, Hawk P, Iwashina K, Inoue D, Suzuki M, et al. A case of severe interstitial lung disease after COVID-19 vaccination. QJM. 2022 Jan 5; 114:(11):805–806. doi: 10.1093/qjmed/hcab263.
    [Google Scholar]
  16. Shimizu T, Watanabe S, Yoneda T, Kinoshita M, Terada N, Kobayashi T, et al. Interstitial pneumonitis after COVID-19 vaccination: A report of three cases. Allergol Int. 2022 Apr; 71:(2):251–253. doi: 10.1016/j.alit.2021.10.003.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/qmj.2022.40
Loading
/content/journals/10.5339/qmj.2022.40
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error